MedTrace Logo

Factors Associated With Dermatoporosis

NCT05037604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 315

Last updated 2021-09-08

No results posted yet for this study

Summary

Dermatoporosis is a chronic syndrome of skin insufficiency or fragility. It is characterized by cutaneous atrophy, senile purpura and stellate pseudoscars. Dermatoporosis prevalence is 37% in ≥65 years.

The objective was to determine factors associated with this diagnosis in \>60 years old patients of the outpatient clinic in the Hospital Central "Dr. Ignacio Morones Prieto " San Luis Potosí, México.

An observational, cross-sectional, descriptive, and analytical study was performed. Patients \>60 years old were selected. A clinical history, clinical examination, and application of a validated diagnostic self-questionnaire were performed.

Conditions

  • Senile Purpura

Interventions

OTHER

Questionnaire about associated factors

Questionnaire about age, prolonged sun exposure, intake of anticoagulants / antiplatelets, intake of oral steroids, chronic kidney disease. Maternal age\> 40 years in their last child , time of lactation per pregnancy and cumulative time of lactation. Age of the first pregnancy and age of menopause onset.

DIAGNOSTIC_TEST

Self questionnaire diagnostic tool

Self questionnaire of physical characteristics

OTHER

Physical Examination

Physical Examination made by a dermatologist

Sponsors & Collaborators

  • Universidad Autonoma de San Luis Potosí

    lead OTHER

Principal Investigators

  • Juan Pablo Castanedo-Cazares, PhD · Universidad Autonoma de San Luis Potosí

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2018-11-30
Completion
2019-04-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05037604 on ClinicalTrials.gov